Amifampridine
Ruzurgi, Firdapse, Zenas (amifampridine) is a small molecule pharmaceutical. Amifampridine was first approved as Ruzurgi on 2009-12-23. It is used to treat lambert-eaton myasthenic syndrome in the USA. It has been approved in Europe to treat lambert-eaton myasthenic syndrome.
Trade Name | Firdapse, Zenas |
---|---|
Common Name | Amifampridine |
Indication | lambert-eaton myasthenic syndrome |
Drug Class |